Innovative Compounds and Inhibitors Paving the Way for Advanced Tuberculosis Treatments

TL;DR
Researchers have developed a promising new compound, CMX410, that targets a vital enzyme in tuberculosis bacteria, showing effectiveness against drug-resistant strains and offering hope for improved treatments for the deadliest infectious disease.
Topics:healthscience#antibiotics#cmx410#drug-resistant-strains#enzyme-inhibition#science#tuberculosis
Want the full story? Read the original reporting
Read on SciTechDaily